Considered and approved the unaudited standalone financial results of the company for the quarter and half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.0 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Salem Erode Investments, a non-banking finance company, reported continued losses in Q2 FY26. Revenue from operations fell sharply to ₹88.62 lakhs from ₹120.44 lakhs in Q2 FY25, a year-on-year decline of about 26%. Total income for the quarter stood at ₹89.96 lakhs versus ₹121.86 lakhs a year ago. The company posted a loss after tax of ₹119.62 lakhs in Q2 FY26, widening from ₹84.64 lakhs in Q2 FY25, with EPS at ₹(1.04). For the half year ended September 2025, the loss after tax was ₹219.05 lakhs against ₹214.98 lakhs in H1 FY25. Operating cash flow remained negative at ₹(421.02) lakhs for H1 FY26. The statutory auditor Mohandas & Associates issued an unmodified (clean) limited review report on the results.
Persistent losses, declining top-line, and negative operating cash flow signal ongoing financial stress for shareholders. The clean auditor opinion is a small positive, but the worsening quarterly performance may weigh on the stock and reflects the company's struggle to achieve profitability in its financing business.